Aier Eye Hospital (East of Chendu), Chendu, China.
Hankou Aier Eye Hospital, Wuhan, 430021, China.
BMC Ophthalmol. 2020 Jul 11;20(1):278. doi: 10.1186/s12886-020-01557-z.
To observe the effects of chalazion and its treatments on meibomian gland function and morphology in the chalazion area.
This nonrandomized, prospective observational clinical study included 58 patients (67 eyelids) who were cured of chalazion, including 23 patients (23 eyelids) treated with a conservative method and 35 patients (44 eyelids) treated with surgery. Infrared meibomian gland photography combined with image analysis by ImageJ software was used to measure the chalazion area proportion. Slit-lamp microscopy was employed to evaluate meibomian gland function, and a confocal microscope was used to observe meibomian gland acinar morphology before treatment and 1 month after complete chalazion resolution.
At 1 month after chalazion resolution, the original chalazion area showed meibomian gland loss according to infrared meibomian gland photography in both groups. In patients who received conservative treatment, the meibomian gland function parameters before treatment were 0.74 ± 0.75, 0.48 ± 0.67, and 1.22 ± 0.60, respectively. One month after chalazion resolution, the parameters were 0.35 ± 0.49, 0.17 ± 0.49, and 0.91 ± 0.60, respectively; there was significant difference (P < 0.05). The proportion of the chalazion area before treatment was 14.90 (11.03, 25.3), and the proportion of meibomian gland loss at 1 month after chalazion resolution was 14.64 (10.33, 25.77); there was no significant difference (P > 0.05). In patients who underwent surgery, the meibomian gland function parameters before surgery were 0.93 ± 0.87, 1.07 ± 0.70, and 1.59 ± 0.76, respectively, and at 1 month after chalazion resolution, they were 0.93 ± 0.82, 0.95 ± 0.75, and 1.52 ± 0.70, respectively; there was no significant difference (P > 0.05). The proportion of the chalazion area before surgery was 14.90 (12.04, 21.6), and the proportion of meibomian gland loss at 1 month after chalazion resolution was 14.84 (11.31, 21.81); there was no significant difference (P > 0.05). The acinar structure could not be observed clearly in the meibomian gland loss area in most patients.
Chalazion causes meibomian gland loss, and the range of meibomian gland loss is not related to the treatment method but to the range of chalazion itself. A hot compress as part of conservative treatment can improve meibomian gland function at the site of chalazion in the short term.
观察霰粒肿及其治疗对霰粒肿区域内的睑板腺功能和形态的影响。
本非随机、前瞻性观察性临床研究纳入了 58 例(67 只眼)已治愈的霰粒肿患者,包括 23 例(23 只眼)接受保守治疗的患者和 35 例(44 只眼)接受手术治疗的患者。采用红外睑板腺照相术结合 ImageJ 软件进行图像分析,测量霰粒肿区域比例。使用裂隙灯显微镜评估睑板腺功能,使用共聚焦显微镜观察治疗前和完全消退后 1 个月的睑板腺腺泡形态。
在霰粒肿消退后 1 个月,两组患者的原始霰粒肿区域均显示睑板腺丢失。在接受保守治疗的患者中,治疗前的睑板腺功能参数分别为 0.74±0.75、0.48±0.67 和 1.22±0.60,消退后 1 个月时分别为 0.35±0.49、0.17±0.49 和 0.91±0.60,差异均有统计学意义(P<0.05)。治疗前霰粒肿区域比例为 14.90(11.03,25.3),消退后 1 个月时睑板腺丢失比例为 14.64(10.33,25.77),差异无统计学意义(P>0.05)。在接受手术治疗的患者中,手术前的睑板腺功能参数分别为 0.93±0.87、1.07±0.70 和 1.59±0.76,消退后 1 个月时分别为 0.93±0.82、0.95±0.75 和 1.52±0.70,差异均无统计学意义(P>0.05)。手术前霰粒肿区域比例为 14.90(12.04,21.6),消退后 1 个月时睑板腺丢失比例为 14.84(11.31,21.81),差异无统计学意义(P>0.05)。大多数患者的睑板腺丢失区域无法清晰观察到腺泡结构。
霰粒肿可导致睑板腺丢失,睑板腺丢失的范围与治疗方法无关,而与霰粒肿本身的范围有关。作为保守治疗一部分的热敷可以在短期内改善霰粒肿部位的睑板腺功能。